Latest OTC-Drugs News

[Comment] Inhibition of PCSK9 in familial hypercholesterolaemiaStatins are indicated for treatment of patients with heterozygous familial hypercholesterolaemia: these drugs inhibit hepatic cholesterol synthesis and indirectly raise transcription and expression of low-density lipoprotein (LDL) receptors, resultin...

Natural Treatment and Maintenance of Prostate Enlargement with New Thermobalancing Therapy Improves Men’s Well-being in Safety States Fine TreatmentFine Treatment recommends new Thermobalancing Therapy as successful natural solution for benign prostatic hyperplasia that is also the most cost-effective prostate treatment on the market. While long-term medication courses and BPH surgeries may cost thousands of dollars, the price of Dr. Allen’s Device for Prostate Treatment under $150 makes it widely affordable. London, UK (PRWEB) May 26, 2012...

DoctorsHealthPress.com Reports on Study Showing the Role of Biofeedback in the Treatment of Esophageal DisordersThe Doctors Health Press, a publisher of various natural health newsletters, books and reports, including the popular online Doctors Health Press e-Bulletin, is reporting on a study that shows the role of biofeedback in the treatment of patients with esophageal disorders. Boston, MA (PRWEB) May 26, 2012 The Doctors Health Press, a publisher of various natural health newsletters, books and reports...

Cannabis Science Gets Set to Release “Phytiva” Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc.Cannabis Science, Inc. (OTCBB: CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to provide insight on the upcoming release of its’ new over-the-counter skin and nutraceutical product line to be branded “Phytiva” through its newest venture Phytiva Pharmaceuticals Inc. The Company is working as...

Delcath raises $20 millionDrug delivery company Delcath Systems Inc. (NASDAQ:DCTH) raised $20 million through the sale of 13.3 million units at $1.50 per unit in a follow-on underwritten by Cowen; Wedbush; and Roth. Each unit comprises a share and a three-year warrant to purc...

ODAC meeting to discuss RCC imagingFDA's Oncologic Drugs Advisory Committee (ODAC) will meet on July 25 to discuss the extent of useful clinical information provided by an imaging test for clear cell renal cell carcinoma (RCC) before surgery. FDA will also review the development strat...

House to vote on PDUFA bill next weekThe U.S. House of Representatives will vote on its version of PDUFA reauthorization legislation next Wednesday, according to a memo sent to House Republicans by Majority Leader Eric Cantor (R-Va.). Cantor hopes to reach an agreement with the Senate b...

Albemarle to increase ibuprofen pricesBATON ROUGE, La., May 25, 2012 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global developer, manufacturer and marketer of highly engineered specialty chemicals, announced today that it will increase global prices for all grades of ibuprofen by an estimated 15% effective immediately, or as contracts allow. (Logo: http://photos.prnewswire.com/prnh/20111129/MM14279LOGO ) Albema...

Cancer Imaging In Clear Cell Renal Carcinoma Gets ODAC Attention As Pipeline FillsFDA’s Oncologic Drugs Advisory Committee will examine the extent (if any) to which the pre-surgical identification of clear cell carcinoma of the kidney using an imaging test provides useful clinical information. ASCO abstracts show considerable re...

IBD drugs may have no role in birth defectsNEW YORK (Reuters Health) - For pregnant patients with inflammatory bowel disease (IBD), the highest source of risk to the fetus may be the disease itself, and not the drugs taken for it, new data suggest.

Device May Inject Variety of Drugs Without Using NeedlesResearchers have engineered a device that delivers a tiny, high-pressure jet of medicine through the skin without the use of a hypodermic needle.

Guangdong’s 2012 Drug Procurements Show Increased Quality FocusGuangdong’s 2012 drug procurement policy will resemble its 2011 predecessor that set fixed prices for low-priced drugs and slightly raised price caps for drugs with higher production costs.

New Chinese Formulary To See More Chronic Illness MedsChina will increase the number of essential drugs for chronic diseases, according to the Ministry of Health.

15 South Korea Pharmas In Potential Battle With Pfizer Over Viagra GenericSouth Korea could become a battleground between local makers of generic drugs and Pfizer Inc. over the latter’s erectile-dysfunction drug Viagra (sildenafil) and its alleged patent protection.

New Drugs For Bad Bugs? John Rex DiscussesYesterday, several European drugmakers – including GlaxoSmithKline and Sanofi – agreed to work with academics to combat antimicrobial resistance and speed the delivery of new antibiotics. The $285 million effort, called NewDrugs4BadBugs,...

FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis MegluminePfizer Inc. has announced that the FDA's Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine.

India Pharmas Stiff-Arm Agency Request For Old Drug-Overcharge DataIndia’s Department of Pharmaceuticals has not received a single response from the nation’s drug makers to a February request for the amount each overcharged for its drugs, part of a dispute dating back to 1987.

Generics makers cannot gain access to some brand-name drugsGenerics manufacturers trying to create generics for certain drugs are having problems gaining access to samples of the brand-name drugs due to restrictions on supply put in place by FDA.

SOCMA's Bulk Pharmaceuticals Task Force Hails Senate Passage of FDA User Fee BillUrges the House to Follow Suit WASHINGTON, May 25, 2012 /PRNewswire-USNewswire/ -- The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates (SOCMA), today commended the Senate for approving the Food and Drug Administration Safety and Innovation Act (S. 2516), bringing the nation one step closer to a safer drug supply chain. The legi...

US Senator calls for prizes not patents for drug discoveryA radical idea has been proposed by a US Senator calling for patents on drugs to be scrapped and instead an annual prize fund set up, which would reward the discovery of new treatments. These treatments would then, due to competition, become availabl...

What's Hot at ASCO This Year?ASCO 2012: This year's theme is 'collaborating to conquer cancer'; a look through the information to be presented shows several drugs with novel mechanisms of action. Medscape Medical News

FDA advisory panel gives mixed views on Pfizer's tafamidisThe US Food and Drug Administration's peripheral and Central Nervous System Drugs Advisory Committee yesterday voted on pharma behemoth Pfizer's (NYSE: PFE) clinical data package for tafamidis meglumine expressing mixed views on the data submitted, w...

Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-ChangerBOSTON (TheStreet) -- This week's Biotech Stock Mailbag focuses on two big topics, the upcoming ASCO cancer meeting and Celldex Therapeutics (with some Galena Biopharma thrown in for kicks). I also take a rare detour from biotech stocks to write abou...

Jet Device Injects Drugs Without NeedlesThe prospect of less painful medicine shots without needles came a step closer this month, as US researchers revealed how they have developed a device that delivers a controlled, tiny, high-pressure jet into the skin without using a hyperdermic need...

Researchers identify key brain cell in antidepressant action(Medical Xpress) -- Antidepressant medications such as Prozac have helped improve mood and lessen anxiety in millions of people with major depression. But scientists know surprisingly little about how these drugs work.

0 1 2 3 4 ›»

buy OTC-Drugs market research data and corporate reports now Advertisement